Dr. Seth H. Berk

Naomi Haas is an Oncologist in Philadelphia, Pennsylvania. Dr. Haas is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. Her top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Haas is currently accepting new patients.

Philosophy of care | Personalized care starts during my first meeting with a patient and family. That's when I get to know the patient as completely as possible. I want to know about the patient's concerns, values and support system so I can provide care that is specific to him or her. | Also, I am a member of the skin and soft tissue cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | When I was young, I didn't like seeing doctors. It created a lot of anxiety for me. Now that I'm older, I can relate to the way people feel, especially when they're coping with the emotions caused by a serious condition like cancer. My grandmother died of uterine cancer in the 1960s. During her battle, I felt helpless. That is what attracted me to cancer research. Now I see the amazing progress we are making through cancer research. | Community involvement | I served on the state board of the American Cancer Society. Today, I take more of a grassroots approach to offer my support. I participate in events, such as 5K runs, that benefit charities. Dr. Nair is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Adult Soft Tissue Sarcoma, and Melanoma.

Daniel Geynisman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Geynisman is rated as an Elite provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.